Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
Nicholas Conrad Smith currently holds 26,866 shares of Alto Neuroscience, Inc. (ANRO), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Nicholas Conrad Smith has been a net buyer of ANRO stock. They have purchased $125.6K and sold $0 worth of shares.
Nicholas Conrad Smith's most recent insider trade was on Mar 28, 2024, when they purchased 4,550 shares at $16.56 per share.
Nicholas Conrad Smith serves as Executive at Alto Neuroscience, Inc. (ANRO). They have executed 5 insider transactions totaling $125.6K over their tenure at the company.
Nicholas Conrad Smith holds the position of Executive at Alto Neuroscience, Inc., where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 2 years and currently hold a stake valued at $0.
Nicholas Conrad Smith has shown a buying trading pattern, with $125.6K in total purchases and $0 in total sales across all transactions. Their most recent activity indicates a tendency to accumulate shares.
The largest transaction by Nicholas Conrad Smith was on Mar 28, 2024, when they purchased $75.3K worth of ANRO shares. This transaction involved 4,550 shares at $16.56 per share.
Nicholas Conrad Smith currently owns 26,866 shares of Alto Neuroscience, Inc. (ANRO), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.
All of Nicholas Conrad Smith's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. Nicholas Conrad Smith has 5 Form 4 filings on record as an insider at Alto Neuroscience, Inc..
Set alerts for Nicholas Conrad Smith and 40,000+ other insiders.